ACCESS TO ADVANCED HEALTH INSTITUTE: Form 990, tax year 2019
View the entire original 990 at ProPublica ↗
- Organization
- ACCESS TO ADVANCED HEALTH INSTITUTE (EIN 91-1608978)
- Tax period
- 2019-01-01 to 2019-12-31
- Filed
- 2021-02-08
- IRS object ID
- 202110399349300821
- Schema version
- 2019v5.2
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule D
- Schedule F
- Schedule I
- Schedule J
- Schedule N
- Schedule O
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2021-02-08T11:02:03-06:00 | ReturnTs |
| Tax Period End | 2019-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 911194016 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | CLARK NUBER PS | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 10900 NE 4TH STREET SUITE 1400 | AddressLine1Txt |
| City | BELLEVUE | CityNm |
| State Abbreviation | WA | StateAbbreviationCd |
| ZIP | 98004 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2019-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 911608978 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | INFECTIOUS DISEASE RESEARCH INSTITUTE | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | INFE | BusinessNameControlTxt |
| Phone | 2063810883 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1616 EASTLAKE AVE E NO 400 | AddressLine1Txt |
| City | SEATTLE | CityNm |
| State Abbreviation | WA | StateAbbreviationCd |
| ZIP | 98102 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | NEIL O'CONNOR | PersonNm |
| Person Title | COO, CFO | PersonTitleTxt |
| Phone | 2063810883 | PhoneNum |
| Signature | 2021-02-06 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | SARA ELIZABETH J HYRE | PreparerPersonNm |
| PTIN | P00235495 | PTIN |
| Phone | 4254544919 | PhoneNum |
| Preparation | 2021-02-08 | PreparationDt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2019 | TaxYr |
| Build TS | 2022-09-23 18:48:47Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | COREY CASPER | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1616 EASTLAKE AVE E NO 400 | AddressLine1Txt |
| City | SEATTLE | CityNm |
| State Abbreviation | WA | StateAbbreviationCd |
| ZIP | 98102 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $27,898,082 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.IDRI.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1993 | FormationYr |
| Legal Domicile State | WA | LegalDomicileStateCd |
| Activity Or Mission | DEVELOP VACCINES, ADJUVANTS, DIAGNOSTICS & DRUGS TO PREVENT, DETECT & TREAT INFECTIOUS DISEASES OF GLOBAL IMPORTANCE. | ActivityOrMissionDesc |
| Contract Termination | Yes (X) | ContractTerminationInd |
| Voting Members Governing Body | 0 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 0 | VotingMembersIndependentCnt |
| Total Employee | 147 | TotalEmployeeCnt |
| Total Volunteers | 6 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $15,418,545 | PYContributionsGrantsAmt |
| CY Contributions Grants | $11,251,999 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $13,483,827 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $11,179,733 | CYProgramServiceRevenueAmt |
| PY Investment Income | $38,533 | PYInvestmentIncomeAmt |
| CY Investment Income | -$465,831 | CYInvestmentIncomeAmt |
| PY Other Revenue | $13,225 | PYOtherRevenueAmt |
| CY Other Revenue | $10,115 | CYOtherRevenueAmt |
| PY Total Revenue | $28,954,130 | PYTotalRevenueAmt |
| CY Total Revenue | $21,976,016 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $493,450 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $1,739,026 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $12,611,006 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $12,177,738 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $559,271 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $15,896,565 | PYOtherExpensesAmt |
| CY Other Expenses | $15,130,135 | CYOtherExpensesAmt |
| PY Total Expenses | $29,001,021 | PYTotalExpensesAmt |
| CY Total Expenses | $29,046,899 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | -$46,891 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | -$7,070,883 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $28,838,131 | TotalAssetsBOYAmt |
| Total Assets EOY | $16,784,379 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $23,875,963 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $20,143,498 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $4,962,168 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | -$3,359,119 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | AS A "NONPROFIT BIOTECH," IDRI COMBINES THE HIGH-QUALITY SCIENCE OF A RESEARCH ORGANIZATION WITH THE PRODUCT DEVELOPMENT CAPABILITIES OF A BIOTECH COMPANY TO CREATE NEW DIAGNOSTICS, DRUGS AND VACCINES FOR INFECTIOUS DISEASES AND IMPROVE THE HEALTH OF THE WORLD. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $9,666,769 | ExpenseAmt |
| Grant | $1,739,026 | GrantAmt |
| Revenue | $2,921,738 | RevenueAmt |
| Desc | VACCINE RESEARCH - IDRI SCIENTISTS ARE DEVELOPING INNOVATIVE VACCINES TO COMBAT THE DEADLIEST OF NEGLECTED TROPICAL DISEASES AS WELL AS THE MOST COMMON AND ENABLE LOCAL PRODUCTION OF THESE VACCINES. BEYOND THEIR ROLE IN PREVENTING DISEASE, THESE VACCINES CAN ALSO BE USED AS THERAPEUTIC AGENTS AND TO PREVENT RECURRENCE IN AFFECTED INDIVIDUALS. IDRI TARGETS INFECTIOUS DISEASES SUCH AS TUBERCULOSIS, LEPROSY AND LEISHMANIASIS, AS WELL AS NEWLY EMERGING THREATS INCLUDING ZIKA AND CHIKUNGUNYA. THE GOAL OF IDRI'S VACCINE WORK IS TO PRODUCE SAFE, EFFECTIVE AND LOW-COST VACCINES AND TO TRANSFER VACCINE TECHNOLOGY AND EXPERTISE TO DEVELOPING COUNTRIES TO DELIVER VACCINES TO THE PEOPLE WHO NEED THEM THE MOST. IDRI SCIENTISTS ARE DEVELOPING AND MANUFACTURING NEXT GENERATION VACCINES INCLUDING THOSE BASED ON RNA TECHNOLOGY, TO RESPOND QUICKLY WHEN DISEASE OUTBREAKS OCCUR. IDRI HAS A ROBUST PIPELINE OF NEW VACCINE CANDIDATES WHICH ARE MOVING SUCCESSFULLY THROUGH EARLY CLINICAL TRIALS. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $5,208,773 | ExpenseAmt |
| Revenue | $1,993,916 | RevenueAmt |
| Desc | TUBERCULOSIS DRUG DISCOVERY - IDRI'S TUBERCULOSIS DRUG DISCOVERY GROUP IS FOCUSED ON DISCOVERING AND DEVELOPING NOVEL DRUGS THAT ARE EFFECTIVE AT CURING DRUG SENSITIVE AND DRUG RESISTANT TB WITH THE ADDED GOAL OF SHORTENING THE TIME IT TAKES TO CURE DISEASE. TO DATE, SCIENTISTS AT IDRI HAVE SCREENED MORE THAN HALF A MILLION COMPOUNDS, CONTINUING THE IDENTIFICATION OF NEW LEADS AND DRUG TARGETS TO COMBAT TB. IDRI IS A FOUNDING MEMBER OF THE LILLY TB DRUG DISCOVERY INITIATIVE - HEADQUARTERED AT IDRI - AND THE TB DRUG ACCELERATOR (TBDA). THE LILLY INITIATIVE IS A UNIQUE PUBLIC-PRIVATE PARTNERSHIP WITH ELI LILLY AND COMPANY AND THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID), PART OF THE NATIONAL INSTITUTES OF HEALTH (NIH), WITH A FOCUS ON THE DISCOVERY OF NEW ANTI-TUBERCULOSIS DRUGS. THE TBDA WAS FOUNDED AS A PARTNERSHIP OF SEVEN PHARMACEUTICAL COMPANIES AND FIVE OTHER ORGANIZATIONS, FUNDED IN PART BY THE BILL & MELINDA GATES FOUNDATION, TO TARGET THE DISCOVERY OF NEW TB DRUGS BY COLLABORATING ON EARLY-STAGE DRUG DISCOVERY FOR TUBERCULOSIS. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $2,659,326 | ExpenseAmt |
| Revenue | $2,992,514 | RevenueAmt |
| Desc | ADJUVANT RESEARCH - ADJUVANTS ARE POWERFUL SYNTHETIC SUBSTANCES WHICH CAN BE ADDED TO VACCINES TO ENHANCE THE ABILITY OF ANTIGENS TO STIMULATE THE BODY'S IMMUNE RESPONSE. IDRI SCIENTISTS ARE PIONEERS IN OPTIMIZING ADJUVANT AND VACCINE FORMULATIONS AND IDRI POSSESS THE WORLD'S LEADING PORTFOLIO OF ADJUVANT FORMULATIONS. THEY PROVIDE A KEY BENEFIT TO VACCINE DEVELOPMENT BY: IMPROVING IMMUNE RESPONSE, BROADENING VACCINE PROTECTION AND REDUCING THE AMOUNT OF VACCINE NEEDED. IDRI SCIENTISTS HAVE DEVELOPED MOLECULES THAT STIMULATE AN EARLY WARNING IN THE BODY'S IMMUNE SYSTEM CAUSING A POWERFUL, BROAD IMMUNE RESPONSE TO DEFINED ANTIGENS. THEY ARE FOCUSING ON HOW THAT STIMULATION TRANSLATES INTO BROAD PROTECTION AGAINST VARIOUS PATHOGENS AND HELPS REDUCE THE REQUIRED VACCINE DOSE AND NUMBER OF SHOTS A PATIENT MAY NEED. IDRI'S DEEP EXPERIENCE IN ADJUVANT DEVELOPMENT PROVIDES A UNIQUE DEPTH OF KNOWLEDGE OF REGULATORY REQUIREMENTS OF BOTH US AND FOREIGN REGULATORY AGENCIES. | Desc |
Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp (2 entries)
| ExpenseExpenseAmt | RevenueRevenueAmt | DescDesc |
|---|---|---|
| $2,674,949 | $1,509,248 | IDRI'S CLINICAL GROUP DESIGNS AND CONDUCTS EARLY STAGE CLINICAL TRIALS TO TEST THE VACCINE CANDIDATES IDENTIFIED BY IDRI SCIENTISTS OR COLLABORATORS. THROUGH OUR NETWORK OF GLOBAL COLLABORATIONS AND WITH DEEP KNOWLEDGE OF REGULATORY PROCESSES AND PROCEDURES IN THE US AND FOREIGN COUNTRIES, THE CLINICAL TEAM IS ABLE TO LAUNCH CLINICAL TRIALS ALMOST ANYWHERE IN THE WORLD. |
| $1,537,274 | $1,762,317 | MANUFACTURING - WITH SUPPORT FROM THE U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, IDRI HAS CREATED A COMMERCIAL SCALE MANUFACTURING CAPABILITY THAT ALLOWS RAPID SCALE-UP AND PRODUCTION AND COMPLETES IDRI'S UNIQUE VACCINE DISCOVERY-DEVELOPMENT PROCESS. WITH ITS MANUFACTURING CAPABILITIES, IDRI IS LEADING THE WAY IN HELPING PREPARE THE WORLD IN CASE ON ANOTHER PANDEMIC FLU OUTBREAK. IDRI HAS DEMONSTRATED ITS ABILITY TO PRODUCE 200 LITERS OF ITS SE ADJUVANT IN JUST A SINGLE DAY ENOUGH TO ENABLE 5 MILLION DOSES OF VACCINE IN CAUSE OF AN OUTBREAK. CONCURRENTLY, WHEN IDRI SCIENTISTS IDENTIFY A VACCINE CANDIDATE IN THE LABORATORY, THIS MANUFACTURING CAPABILITY ENABLES THEM TO APPLY THAT DISCOVERY BY PRODUCING VACCINES UNDER CONTROLLED CONDITIONS SO THAT THEY ARE SUITABLE FOR USE IN HUMAN STUDIES. THIS ENABLES IDRI TO MOVE A VACCINE FROM LATE STAGE RESEARCH TO EARLY CLINICAL STUDIES. |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Prog Srvc Expense | $4,212,223 | TotalOtherProgSrvcExpenseAmt |
| Total Other Prog Srvc Revenue | $3,271,565 | TotalOtherProgSrvcRevenueAmt |
| Total Program Service Expenses | $21,747,091 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | 0 | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | 0 | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (1) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (1) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | 0 | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (1) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | 0 | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | 0 | ForeignOfficeInd |
| Foreign Activities | Yes (1) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (1) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | 0 | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | 0 | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | 0 | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | Yes (1) | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | 0 | RelatedEntityInd |
| Related Organization Ctrl Ent | 0 | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 34 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 147 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | 0 | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | 0 | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 0 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 0 | IndependentVotingMemberCnt |
| Family Or Business Rln | 0 | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | 0 | MembersOrStockholdersInd |
| Election Of Board Members | 0 | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | 0 | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | NEIL O'CONNOR | PersonNm |
| Phone | 2063810883 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1616 EASTLAKE AVE E SUITE 400 | AddressLine1Txt |
| City | SEATTLE | CityNm |
| State Abbreviation | WA | StateAbbreviationCd |
| ZIP | 98102 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (22 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Key EmployeeKeyEmployeeInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | OfficerOfficerInd | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|
| MICHAEL BASSOF | ||||||||
| EVP, PHILANTHROPY | 40.00 | Yes (X) | $416,199 | $0 | $23,971 | |||
| COREY CASPER | ||||||||
| INTERIM PRESIDENT & CEO | 40.00 | $388,432 | $0 | $23,147 | Yes (X) | |||
| STEVEN REED PH D | ||||||||
| FOUNDER, DISTINGUISHED INVESTIGATOR | 32.00 | $359,201 | $0 | $27,246 | Yes (X) | Yes (X) | ||
| ANNA MARIE BECKMANN | ||||||||
| SVP, DEVELOPMENT & REGULATORY | 40.00 | Yes (X) | $240,005 | $0 | $28,767 | |||
| RHEA COLER | ||||||||
| SVP, PRE-CLIN. & TRANSL. RESEARCH | 40.00 | Yes (X) | $214,552 | $0 | $24,393 | |||
| TANYA PARISH | ||||||||
| SVP, DRUG DISCOVERY | 40.00 | Yes (X) | $216,265 | $0 | $9,392 | |||
| WINSTON WINCOMB | ||||||||
| DIR. OF VIVARIUM | 40.00 | Yes (X) | $182,577 | $0 | $21,738 | |||
| CHRISTOPHER FOX | ||||||||
| VP, FORMULATIONS | 40.00 | Yes (X) | $156,665 | $0 | $26,646 | |||
| LINDA HAWKINS | ||||||||
| DIR. QUALITY ASSURANCE & COMPLIANCE | 40.00 | Yes (X) | $151,555 | $0 | $22,114 | |||
| CHRISTOPHER ANTONY | ||||||||
| VP, OPERATIONS | 40.00 | Yes (X) | $156,845 | $0 | $12,855 | |||
| RYAN KRAMER | ||||||||
| DIR., PROCESS & PRODUCT DEV. | 40.00 | $137,544 | $0 | $23,084 | Yes (X) | |||
| ROBRICK SMITH | ||||||||
| DIR., INFORMATION TECHNOLOGY | 40.00 | $134,879 | $0 | $24,173 | Yes (X) | |||
| AUDE FREVOL | ||||||||
| ASSOC. DIRECTOR, CLINICAL OPS. | 40.00 | $131,927 | $0 | $25,168 | Yes (X) | |||
| JESSE ERASMUS | ||||||||
| POSTDOCTORAL FELLOW | 40.00 | $126,159 | $0 | $23,493 | Yes (X) | |||
| ERIK LAURSEN | ||||||||
| DIRECTOR, GMP OPERATIONS | 40.00 | $125,628 | $0 | $14,953 | Yes (X) | |||
| RICHARD LAUTCH | ||||||||
| COO | 40.00 | $53,071 | $0 | $2,780 | Yes (X) | |||
| FRANKLYN PRENDERGAST MD PHD | ||||||||
| CHAIRMAN | 5.00 | $0 | $0 | $0 | Yes (X) | Yes (X) | ||
| NORMAN BAYLOR PH D | ||||||||
| DIRECTOR | 1.00 | $0 | $0 | $0 | Yes (X) | |||
| MICHEL DEWILDE PH D | ||||||||
| DIRECTOR | 1.00 | $0 | $0 | $0 | Yes (X) | |||
| MASSIMO RADAELLI PH D | ||||||||
| DIRECTOR | 1.00 | $0 | $0 | $0 | Yes (X) | |||
| JERRY MCDOUGALL | ||||||||
| DIRECTOR | 1.00 | $0 | $0 | $0 | Yes (X) | |||
| ERIK IVERSON | ||||||||
| DIRECTOR | 1.00 | $0 | $0 | $0 | Yes (X) | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $3,191,504 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $333,920 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 31 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt | Address Line1ContractorAddress/ForeignAddress/AddressLine1Txt | CityContractorAddress/ForeignAddress/CityNm | Province Or StateContractorAddress/ForeignAddress/ProvinceOrStateNm | CountryContractorAddress/ForeignAddress/CountryCd | Foreign PostalContractorAddress/ForeignAddress/ForeignPostalCd |
|---|---|---|---|---|---|---|---|---|---|---|
| LGENIA INC | ||||||||||
| 412 S MAPLE ST SUITE 104 | FORTVILLE | IN | 46040 | RESEARCH | $1,250,000 | |||||
| FUNDACAO BUTANTAN | ||||||||||
| RESEARCH | $389,752 | AV VITAL BRAZIL 1500 | SAO PAULO | SP | BR | 05503-900 | ||||
| MORNINGSIDE TRANSLATIONS LLC | ||||||||||
| 450 7TH AVE SUITE 1001 | NEW YORK | NY | 10123 | LANGUAGE SERVICES | $266,034 | |||||
| THOMSON LAW PLLC | ||||||||||
| 838 CHRISTIAN WAY | BELLINGHAM | WA | 98229 | LEGAL FEES | $248,570 | |||||
| DAVID KEOGH | ||||||||||
| 8015 23RD AVE NW | SEATTLE | WA | 98117 | MANAGEMENT CONSULTING | $172,750 | |||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 15 | CntrctRcvdGreaterThan100KCnt |
| Government Grants | $7,943,729 | GovernmentGrantsAmt |
| All Other Contributions | $3,308,270 | AllOtherContributionsAmt |
| Total Contributions | $11,251,999 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp (2 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt |
|---|---|---|---|
| SERVICES AND CONTRACTS | 541700 | $9,593,900 | $9,593,900 |
| LICENSING | 541700 | $1,585,833 | $1,585,833 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $11,179,733 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $3,308 | TotalRevenueColumnAmt |
| Exclusion | $3,308 | ExclusionAmt |
Gross Rents GrossRentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $10,128 | RealAmt |
Less Rental Expenses LessRentalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $0 | RealAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $10,128 | RealAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $10,128 | TotalRevenueColumnAmt |
| Exclusion | $10,128 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $5,452,927 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $5,430,268 | SecuritiesAmt |
| Other | $491,798 | OtherAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $22,659 | SecuritiesAmt |
| Other | -$491,798 | OtherAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$469,139 | TotalRevenueColumnAmt |
| Exclusion | -$469,139 | ExclusionAmt |
Other Revenue Misc OtherRevenueMiscGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | FOREIGN CURRENCY LOSS | Desc |
| Business | 900099 | BusinessCd |
| Total Revenue Column | -$13 | TotalRevenueColumnAmt |
| Exclusion | -$13 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | -$13 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $21,976,016 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $11,179,733 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | -$455,716 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,451,927 | TotalAmt |
| Program Services | $1,451,927 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $287,099 | TotalAmt |
| Program Services | $287,099 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,659,118 | TotalAmt |
| Program Services | $1,853,182 | ProgramServicesAmt |
| Management And General | $375,847 | ManagementAndGeneralAmt |
| Fundraising | $430,089 | FundraisingAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $7,447,515 | TotalAmt |
| Program Services | $5,718,447 | ProgramServicesAmt |
| Management And General | $1,682,214 | ManagementAndGeneralAmt |
| Fundraising | $46,854 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $257,486 | TotalAmt |
| Program Services | $189,750 | ProgramServicesAmt |
| Management And General | $58,114 | ManagementAndGeneralAmt |
| Fundraising | $9,622 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,099,746 | TotalAmt |
| Program Services | $834,296 | ProgramServicesAmt |
| Management And General | $235,272 | ManagementAndGeneralAmt |
| Fundraising | $30,178 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $713,873 | TotalAmt |
| Program Services | $542,544 | ProgramServicesAmt |
| Management And General | $149,913 | ManagementAndGeneralAmt |
| Fundraising | $21,416 | FundraisingAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $820,651 | TotalAmt |
| Management And General | $820,651 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $85,858 | TotalAmt |
| Management And General | $85,858 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $202,917 | TotalAmt |
| Program Services | $147,710 | ProgramServicesAmt |
| Management And General | $52,007 | ManagementAndGeneralAmt |
| Fundraising | $3,200 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $20,587 | TotalAmt |
| Program Services | $11,449 | ProgramServicesAmt |
| Management And General | $4,945 | ManagementAndGeneralAmt |
| Fundraising | $4,193 | FundraisingAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $73,615 | TotalAmt |
| Program Services | $1,084 | ProgramServicesAmt |
| Management And General | $64,131 | ManagementAndGeneralAmt |
| Fundraising | $8,400 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $316,733 | TotalAmt |
| Program Services | $50,071 | ProgramServicesAmt |
| Management And General | $266,662 | ManagementAndGeneralAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $438,633 | TotalAmt |
| Management And General | $438,633 | ManagementAndGeneralAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,927,216 | TotalAmt |
| Program Services | $2,215,619 | ProgramServicesAmt |
| Management And General | $706,278 | ManagementAndGeneralAmt |
| Fundraising | $5,319 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $307,604 | TotalAmt |
| Program Services | $202,855 | ProgramServicesAmt |
| Management And General | $104,749 | ManagementAndGeneralAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $17,487 | TotalAmt |
| Program Services | $14,867 | ProgramServicesAmt |
| Management And General | $2,620 | ManagementAndGeneralAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $22,637 | TotalAmt |
| Management And General | $22,637 | ManagementAndGeneralAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,461,900 | TotalAmt |
| Program Services | $2,226,289 | ProgramServicesAmt |
| Management And General | $235,611 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $146,259 | TotalAmt |
| Management And General | $146,259 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt |
|---|---|---|---|
| LAB SUPPLIES | $4,257,656 | $3,981,353 | $276,303 |
| SUBCONTRACTS | $1,382,750 | $1,210,000 | $172,750 |
| REPAIRS & MAINTENANCE | $614,268 | $471,452 | $142,816 |
| UBI TAX | $6,633 | $6,633 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,026,731 | TotalAmt |
| Program Services | $337,097 | ProgramServicesAmt |
| Management And General | $689,634 | ManagementAndGeneralAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $29,046,899 | TotalAmt |
| Program Services | $21,747,091 | ProgramServicesAmt |
| Management And General | $6,740,537 | ManagementAndGeneralAmt |
| Fundraising | $559,271 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,684,044 | BOYAmt |
| EOY | $560,115 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,306,530 | BOYAmt |
| EOY | $883,783 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,225,598 | BOYAmt |
| EOY | $1,797,762 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,011,369 | BOYAmt |
| EOY | $1,072,560 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $968,886 | BOYAmt |
| EOY | $777,142 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $283,189 | BOYAmt |
| EOY | $165,515 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $26,536,181 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $15,117,533 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $14,213,861 | BOYAmt |
| EOY | $11,418,648 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $115,104 | BOYAmt |
| EOY | $108,854 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $29,550 | BOYAmt |
| EOY | $0 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $28,838,131 | BOYAmt |
| EOY | $16,784,379 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,488,337 | BOYAmt |
| EOY | $2,457,537 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $6,414,233 | BOYAmt |
| EOY | $3,562,652 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $1,524,610 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $13,973,393 | BOYAmt |
| EOY | $12,598,699 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $23,875,963 | BOYAmt |
| EOY | $20,143,498 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $325,212 | BOYAmt |
| EOY | -$5,345,681 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,636,956 | BOYAmt |
| EOY | $1,986,562 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,962,168 | BOYAmt |
| EOY | -$3,359,119 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $28,838,131 | BOYAmt |
| EOY | $16,784,379 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | -$7,070,883 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | -$1,849 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | -$1,248,555 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | Yes (1) | FederalGrantAuditRequiredInd |
| Federal Grant Audit Performed | Yes (1) | FederalGrantAuditPerformedInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $18,340,233 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $10,055,782 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $11,656,120 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $14,143,765 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $11,251,999 | CurrentTaxYearAmt |
| Total | $65,447,899 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $18,340,233 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $10,055,782 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $11,656,120 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $14,143,765 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $11,251,999 | CurrentTaxYearAmt |
| Total | $65,447,899 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $7,405,238 | SubstantialContributorsTotAmt |
| Public Support Total170 | $58,042,661 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $1,672,937 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $1,003,630 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $941,071 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $45,438 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $13,436 | CurrentTaxYearAmt |
| Total | $3,676,512 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $11,373 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $8,216 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $70,307 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | -$536 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | -$13 | CurrentTaxYearAmt |
| Total | $89,347 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $69,213,758 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $51,090,391 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.83860 | PublicSupportCY170Pct |
| Public Support PY170 | 0.76970 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Form990 Schedule A Part VI Form990ScheduleAPartVIGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: | FormAndLineReferenceDesc |
| Explanation | MISCELLANEOUS - 2017 AMOUNT: $ 70,307. REIMBURSEMENTS - 2016 AMOUNT: $ 413. STORAGE - 2016 AMOUNT: $ 7,803. CURRENCY EXCHANGE - 2015 AMOUNT: $ 11,373. 2018 AMOUNT: $ -536. 2019 AMOUNT: $ -13. | ExplanationTxt |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule D IRS990ScheduleD
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $15,217,676 | OtherCostOrOtherBasisAmt |
| Depreciation | $6,852,425 | DepreciationAmt |
| Book Value | $8,365,251 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $11,318,505 | OtherCostOrOtherBasisAmt |
| Depreciation | $8,265,108 | DepreciationAmt |
| Book Value | $3,053,397 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $11,418,648 | TotalBookValueLandBuildingsAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | DEFERRED RENT | Desc |
| Amt | $12,598,699 | Amt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $12,598,699 | TotalLiabilityAmt |
| Total Rev Etc Audited Fincl Stmt | $20,306,978 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | -$1,849 | NetUnrealizedGainsInvstAmt |
| Other Revenue | -$1,667,189 | OtherRevenueAmt |
| Revenue Not Reported | -$1,669,038 | RevenueNotReportedAmt |
| Revenue Subtotal | $21,976,016 | RevenueSubtotalAmt |
| Revenue Not Reported Fincl Stmt | $0 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $21,976,016 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $28,628,265 | TotExpnsEtcAuditedFinclStmtAmt |
| Expenses Not Reported | $0 | ExpensesNotReportedAmt |
| Expenses Subtotal | $28,628,265 | ExpensesSubtotalAmt |
| Other Expenses Not Included | $418,634 | OtherExpensesNotIncludedAmt |
| Expenses Not Rpt Fincl Stmt | $418,634 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $29,046,899 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART XI, LINE 2D - OTHER ADJUSTMENTS: | GRANT WRITE-OFF -36. LOSS ON UNCOLLECTIBLE PLEDGE -1,274,780. ROYALTY EXPENSE -418,634. DISCOUNT ON LONG TERM PLEDGE 26,261. |
| PART XII, LINE 4B - OTHER ADJUSTMENTS: | ROYALTY EXPENSE 418,634. |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | 0 | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (9 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|---|
| EUROPE (INCLUDING ICELAND & GREENLAND) | 0 | 0 | GRANTS TO RECIPIENTS LOCATED IN THE REGION | N/A | $91,925 |
| SOUTH ASIA | 0 | 0 | GRANTS TO RECIPIENTS LOCATED IN THE REGION | N/A | $13,947 |
| EAST ASIA AND THE PACIFIC | 0 | 0 | GRANTS TO RECIPIENTS LOCATED IN THE REGION | N/A | $141,227 |
| NORTH AMERICA | 0 | 0 | GRANTS TO RECIPIENTS LOCATED IN THE REGION | N/A | $40,000 |
| EUROPE (INCLUDING ICELAND & GREENLAND) | 0 | 0 | PROGRAM SERVICES | RESEARCH | $281,195 |
| SOUTH ASIA | 0 | 0 | PROGRAM SERVICES | RESEARCH | $30,425 |
| EAST ASIA AND THE PACIFIC | 0 | 0 | PROGRAM SERVICES | RESEARCH | $26,958 |
| NORTH AMERICA | 0 | 0 | PROGRAM SERVICES | RESEARCH | $75,210 |
| SOUTH AMERICA | 0 | 0 | PROGRAM SERVICES | RESEARCH | $389,752 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 0 | SubtotalEmployeesCnt |
| Continuation Total Office | 0 | ContinuationTotalOfficeCnt |
| Continuation Total Employee | 0 | ContinuationTotalEmployeeCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Subtotal Spent | $700,887 | SubtotalSpentAmt |
| Continuation Spent | $389,752 | ContinuationSpentAmt |
| Total Spent | $1,090,639 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp (5 entries)
| RegionRegionTxt | Purpose Of GrantPurposeOfGrantTxt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt |
|---|---|---|---|
| EAST ASIA AND THE PACIFIC | RESEARCH | $20,793 | WIRE TRANSFER |
| SOUTH ASIA | RESEARCH | $13,947 | WIRE TRANSFER |
| EUROPE (INCLUDING ICELAND & GREENLAND) | RESEARCH | $91,925 | WIRE TRANSFER |
| EAST ASIA AND THE PACIFIC | RESEARCH | $120,434 | WIRE TRANSFER |
| NORTH AMERICA | RESEARCH | $40,000 | WIRE TRANSFER |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 4 | Total501c3OrgCnt |
| Total Other Org | 1 | TotalOtherOrgCnt |
| Transfer To Foreign Corp | 0 | TransferToForeignCorpInd |
| Interest In Foreign Trust | 0 | InterestInForeignTrustInd |
| Foreign Corp Ownership | 0 | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | 0 | PassiveForeignInvestmestCoInd |
| Foreign Partnership | 0 | ForeignPartnershipInd |
| Boycott Countries | 0 | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 3: | THE EXPENDITURES REPORTED ON SCHEDULE F, PART I, LINE 3 ARE ON ACCRUAL BASIS OF ACCOUNTING. |
| PART III ACCOUNTING METHOD: |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (8 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt | Address Line2USAddress/AddressLine2Txt |
|---|---|---|---|---|---|---|---|---|
| ST LOUIS UNIVERSITY | ||||||||
| 3700 W PINE MALL 255 | SAINT LOUIS | MO | 63103 | 430654872 | 501(C)(3) | $280,230 | RESEARCH | |
| COVANCE CLINICAL RESEARCH UNIT | ||||||||
| 3402 KINSMAN BLVD | MADISON | WI | 53704 | 581695239 | $35,633 | RESEARCH | ||
| DFNET RESEARCH INC | ||||||||
| 140 LAKESIDE AVE STE 310 | SEATTLE | WA | 981226538 | 200852149 | $30,734 | RESEARCH | ||
| AMYRIS INC | ||||||||
| 5885 HOLLIS ST STE 100 | EMERYVILLE | CA | 946082059 | 550856151 | $374,856 | RESEARCH | ||
| UNIVERSITY OF VIRGINIA | ||||||||
| 1001 NORTH EMMET STREET PO BOX | CHARLOTTESVILLE | VA | 229044195 | 546001796 | 501(C)(3) | $539,919 | RESEARCH | 400195 |
| RTI INTERNATIONAL | ||||||||
| 3040 EAST CORNWALLIS ROAD | RESEARCH TRIANGLE PARK | NC | 277092194 | 560686338 | $97,504 | RESEARCH | ||
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | ||||||||
| CB 3490 MCCOLL BUILDING | CHAPEL HILL | NC | 275990001 | 566001393 | 501(C)(3) | $7,306 | RESEARCH | |
| COLORADO STATE UNIVERSITY | ||||||||
| 200 WEST LAKE STREET | FORT COLLINS | CO | 805214593 | 846000545 | 501(C)(3) | $85,745 | RESEARCH | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 4 | Total501c3OrgCnt |
| Total Other Org | 4 | TotalOtherOrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | ALL PAYMENTS MADE FOR PROGRAM SERVICES WITHIN THE U.S. ARE BASED ON LEGAL AGREEMENTS BETWEEN IDRI AND THE PARTY RECEIVING PAYMENT. THESE AGREEMENTS INCLUDE REQUIREMENTS FOR BOTH PROGRESS AND FINANCIAL REPORTING BASED ON TIME PERIODS OR MILESTONE ACHIEVEMENTS. REPORTS ARE REVIEWED BY SCIENTIFIC AND ADMINISTRATIVE STAFF TO ENSURE THAT THE GOALS OF THE AGREEMENT AND ANY SPECIFIC FINANCIAL RESTRICTIONS ARE BEING MET BEFORE FURTHER PAYMENT IS MADE. MOST AGREEMENTS ALSO CONTAIN A CLAUSE GIVING IDRI THE RIGHT TO AUDIT FINANCIAL RECORDS OF THE PARTY IF NEEDED. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | Yes (1) | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | Yes (1) | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | 0 | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (13 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MICHAEL BASSOF | ||||||||||||||
| EVP, PHILANTHROPY | $276,199 | $0 | $0 | $0 | $140,000 | $0 | $11,000 | $0 | $12,971 | $0 | $440,170 | $0 | $0 | $0 |
| COREY CASPER | ||||||||||||||
| INTERIM PRESIDENT & CEO | $388,432 | $0 | $0 | $0 | $0 | $0 | $10,568 | $0 | $12,579 | $0 | $411,579 | $0 | $0 | $0 |
| STEVEN REED PH D | ||||||||||||||
| FOUNDER, DISTINGUISHED INVESTIGATOR | $359,201 | $0 | $0 | $0 | $0 | $0 | $11,000 | $0 | $16,246 | $0 | $386,447 | $0 | $0 | $0 |
| ANNA MARIE BECKMANN | ||||||||||||||
| SVP, DEVELOPMENT & REGULATORY | $240,005 | $0 | $0 | $0 | $0 | $0 | $9,756 | $0 | $19,011 | $0 | $268,772 | $0 | $0 | $0 |
| RHEA COLER | ||||||||||||||
| SVP, PRE-CLIN. & TRANSL. RESEARCH | $214,552 | $0 | $0 | $0 | $0 | $0 | $4,011 | $0 | $20,382 | $0 | $238,945 | $0 | $0 | $0 |
| TANYA PARISH | ||||||||||||||
| SVP, DRUG DISCOVERY | $216,265 | $0 | $0 | $0 | $0 | $0 | $7,334 | $0 | $2,058 | $0 | $225,657 | $0 | $0 | $0 |
| WINSTON WINCOMB | ||||||||||||||
| DIR. OF VIVARIUM | $182,577 | $0 | $0 | $0 | $0 | $0 | $5,798 | $0 | $15,940 | $0 | $204,315 | $0 | $0 | $0 |
| CHRISTOPHER FOX | ||||||||||||||
| VP, FORMULATIONS | $156,665 | $0 | $0 | $0 | $0 | $0 | $6,602 | $0 | $20,044 | $0 | $183,311 | $0 | $0 | $0 |
| LINDA HAWKINS | ||||||||||||||
| DIR. QUALITY ASSURANCE & COMPLIANCE | $151,555 | $0 | $0 | $0 | $0 | $0 | $6,220 | $0 | $15,894 | $0 | $173,669 | $0 | $0 | $0 |
| CHRISTOPHER ANTONY | ||||||||||||||
| VP, OPERATIONS | $156,845 | $0 | $0 | $0 | $0 | $0 | $3,676 | $0 | $9,179 | $0 | $169,700 | $0 | $0 | $0 |
| RYAN KRAMER | ||||||||||||||
| DIR., PROCESS & PRODUCT DEV. | $137,544 | $0 | $0 | $0 | $0 | $0 | $5,519 | $0 | $17,565 | $0 | $160,628 | $0 | $0 | $0 |
| ROBRICK SMITH | ||||||||||||||
| DIR., INFORMATION TECHNOLOGY | $134,879 | $0 | $0 | $0 | $0 | $0 | $4,287 | $0 | $19,886 | $0 | $159,052 | $0 | $0 | $0 |
| AUDE FREVOL | ||||||||||||||
| ASSOC. DIRECTOR, CLINICAL OPS. | $131,927 | $0 | $0 | $0 | $0 | $0 | $5,382 | $0 | $19,786 | $0 | $157,095 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 4A | MICHAEL BASSOF RECEIVE A SEVERANCE PAYMENT OF $140,000 IN 2019. |
| PART I, LINE 5 | INVENTOR REVENUES SHARED WITH STEVEN R. REED AND OTHER PATENT HOLDERS WHEN IP IS LICENSED. |
Schedule N IRS990ScheduleN
Disposition Of Assets Detail DispositionOfAssetsDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Assets Distri Or Expnss Paid | ASSETS INCLUDING CASH, ACCOUNTS/PLEDGES RECEIVABLE AND FIXED ASSETS | AssetsDistriOrExpnssPaidDesc |
| Distribution | 2019-12-31 | DistributionDt |
| Fair Market Value Of Asset | $12,314,819 | FairMarketValueOfAssetAmt |
| Method Of FMV Determination | BOOK | MethodOfFMVDeterminationTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Director Of Successor2 | 0 | DirectorOfSuccessor2Ind |
| Employee Of Successor2 | 0 | EmployeeOfSuccessor2Ind |
| Owner Of Successor2 | 0 | OwnerOfSuccessor2Ind |
| Receive Compensation2 | 0 | ReceiveCompensation2Ind |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | FORM 990, SCHEDULE N, PART II: | FormAndLineReferenceDesc |
| Explanation | TO ADDRESS IDRI'S DETERIORATING CASH FLOW POSITION, IN LATE NOVEMBER AND DECEMBER 2019 TWO REDUCTIONS IN FORCE TOOK PLACE, REDUCING IDRI'S HEADCOUNT BY OVER 60%.HOWEVER, THESE ACTIONS PROVED INSUFFICIENT AND ON DECEMBER 20, 2019, AS FURTHER EFFORTS TO RESOLVE THE SITUATION PROVED UNSUCCESSFUL, IDRI'S BOARD OF DIRECTORS VOTED TO PLACE IDRI INTO VOLUNTARY WASHINGTON STATE RECEIVERSHIP AND THE BOARD WAS DISSOLVED. THE RECEIVERSHIP BECAME EFFECTIVE ON JANUARY 2, 2020.IDRI CURRENTLY HAS NO PLANS FOR DISSOLUTION OR LIQUIDATION. THE RECEIVER AND IDRI'S MANAGEMENT HAVE AND WILL CONTINUE TO RESTRUCTURE THE ORGANIZATION'S BUSINESS AND EXPECT TO SUCCESSFULLY EXIT RECEIVERSHIP SOMETIME IN THE SECOND HALF OF 2021. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (6 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART 1, LINE 6: | THERE WERE SIX VOLUNTEER BOARD MEMBERS DURING THE YEAR. BOARD MEMBERS PARTICIPATE IN STRATEGIC PLANNING, FINANCIAL OVERSIGHT, EXECUTIVE LEADERSHIP RECRUITMENT AND SELECTION, BUSINESS DEVELOP STRATEGY, AND SCIENTIFIC ADVICE. THEY COME FROM A VARIETY OF BACKGROUNDS AND DEMONSTRATE FINANCIAL EXPERTISE, LIFE SCIENCES NOT-FOR-PROFIT EXPERTISE, AND AN UNDERSTANDING OF BUSINESS AND BIOTECH LICENSING. |
| FORM 990, PART VI, SECTION B, LINE 11B | A DRAFT COPY OF THE FORM 990 IS PRESENTED TO THE RECEIVER FOR REVIEW. THE RECEIVER REVIEWS AND APPROVES THE FORM 990 ON BEHALF OF IDRI. THE EXECUTIVE MANAGEMENT MEMBERS RECEIVE A COPY OF THE FORM 990 PRIOR TO FILING WITH THE IRS. |
| FORM 990, PART VI, SECTION B, LINE 12C | IN MARCH, MEMBERS OF THE BOARD OF DIRECTORS AND SENIOR MANAGEMENT ARE GIVEN A COPY OF THE CONFLICT OF INTEREST POLICY. THEY ARE REQUIRED TO FILL IT OUT AND RETURN IT BY THE FIRST BOARD MEETING - USUALLY SOMETIME IN THE FIRST QUARTER. THE SENIOR VICE PRESIDENT OF OPERATIONS AND GENERAL COUNSEL REVIEWS THE QUESTIONNAIRES AND SUMMARIZES THE RESULTS. THE RESULTS ARE COMMUNICATED TO THE BOARD OF DIRECTORS. TO THE EXTENT THAT THERE ARE ANY CONFLICTS, THE MEMBER IS RECUSED FROM ANY DECISION MAKING THAT WOULD INCLUDE THE CONFLICT. WHEN THE OCCASION ARISES, THOSE MEMBERS ALSO REMIND THE GROUP (MANAGEMENT TEAM OR BOARD) THAT THERE IS A POTENTIAL CONFLICT WHEN SPECIFIC DISCUSSION TOPICS ARISE. |
| FORM 990, PART VI, SECTION B, LINE 15 | THE COMPENSATION COMMITTEE CONDUCTED A FULL CEO PERFORMANCE AND COMPENSATION REVIEW, INITIATED IN 2017, USING AN OUTSIDE INDEPENDENT CONSULTANT. THE REPORT IS IN THE BOARD MATERIALS AND IN THE PERSONNEL FILE. THE DECISIONS ARE IN THE COMPENSATION COMMITTEE NOTES. COMPARATIVE COMPENSATION INFORMATION WAS USED FROM THE CULPEPPER AND RADFORD PROFESSIONAL COMPENSATION FIRMS. THE BOARD CHAIR ALSO DOES AN ANNUAL REVIEW OF ALL OTHER OFFICERS AND KEY EMPLOYEES AND WORKS WITH THE HUMAN RESOURCES DEPARTMENT TO DETERMINE IF THE COMPENSATION IS ADEQUATE. IF AN ADJUSTMENT IS DEEMED NECESSARY, THE BOARD CHAIR CONVENES THE COMPENSATION COMMITTEE AND THE ADJUSTMENT IS ADDRESSED. THE BOARD CHAIR REPORTS BACK TO THE HUMAN RESOURCES DEPARTMENT WHO FOLLOWS THROUGH WITH THE COMMITTEE'S RECOMMENDATION. |
| FORM 990, PART VI, SECTION C, LINE 19 | REQUESTS FOR INFORMATION SUCH AS AUDITED FINANCIAL STATEMENTS, GOVERNING DOCUMENTS, AND CONFLICT OF INTEREST POLICY ARE HANDLED THROUGH OUR FINANCE DEPARTMENT AND INFORMATION IS DISTRIBUTED AS REQUESTED UNLESS CONFIDENTIAL IN NATURE. |
| FORM 990, PART XI, LINE 9: | LOSS ON UNCOLLECTIBLE PLEDGE -1,274,780. DISCOUNT ON LONG TERM PLEDGE 26,261. GRANT WRITE-OFF -36. |